Back to Authors

Church, Ann

Mayo Clinic

University of Nebraska Medical Center

Citations 1

Cutaneous Atypical Fibroxanthoma With Osteoclast-Like Giant Cell: A Rare but Diagnostic Pitfall
Shaker, Nada , Phelps, Robert , Niedt, George, Patel, Ankush , Wu, Douglas, Prieto, VĂ­ctor G. , Church, Ann, Shaker, Nada , Patel, Ankush U , Aung, Phyu P , Pradhan, Dinesh

The American Journal of Dermatopathology | September 14, 2023 | Volume: 45 | Issue: 10 | Pages: 704-707

10.1097/dad.0000000000002508 Get It

Background: Atypical fibroxanthoma (AFX) is a dermal-based, low-grade neoplasm with no specific lineage of differentiation. The occurrence of AFX with osteoclast-like giant cells is exceptionally rare. Less than 20 cases have been reported in the literature. Case Presentation: A 77-year-old man with a medical history of multiple basal and squamous cell carcinomas of the skin, presented with a progressively growing erythematous nodule on the sun-damaged right central parietal scalp. A shave biopsy showed a dermal spindle cell proliferation accompanied by numerous osteoclast-like multinucleated giant cells and predominant atypical mitotic figures. The immunohistochemical staining showed a diffuse positive staining for CD68 and SMA, patchy staining for CD10, and negative staining for SOX-10, pan-cytokeratin, CK5/6, S100, CD34, and desmin. The tumor was completely excised with negative margins. A subsequent follow-up over a period of 13 months showed no recurrence. Conclusion: Distinguishing AFX with osteoclast-like giant cells from both malignant and benign skin lesions with osteoclast-like giant cells is crucial. Although AFX tumors display worrisome malignant histologic features, most cases have a favorable prognosis with a local recurrence rate below 5% and exceedingly rare metastasis.